Literature DB >> 21317821

Symptom interference with work and relationships during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study.

Nancy Fugate Woods1, Ellen Sullivan Mitchell.   

Abstract

OBJECTIVE: The aim of this study was to describe the changes in symptom interference during the menopausal transition (MT) stages and early postmenopause (PM), including the effects of age, MT-related factors (estrone, follicle-stimulating hormone, testosterone, MT stages), symptoms (hot flashes, depressed mood, awakening during the night, anxiety, backache, joint pain, forgetfulness, and difficulty concentrating), health-related factors (perceived health), and stress-related factors (perceived stress, cortisol).
METHODS: A subset of Seattle Midlife Women's Health Study participants provided data during the late reproductive, early and late MT stages, or early PM (n = 184), including menstrual calendars for staging the MT; annual health reports completed between 1990 and 2008; morning urine samples assayed for estrone glucuronide, follicle-stimulating hormone, and cortisol; and symptom diary ratings several times each year. Interference was rated in the diary along with symptoms, perceived health, and stress. Multilevel modeling with an R program was used to test the patterns of symptom interference related to age, MT-related factors, symptoms, and health- and stress-related factors, with as many as 5,656 observations. Median age was 47.4 years.
RESULTS: Interference with work was significantly associated with individual covariates such as perceived health, stress, hot flashes, depressed mood, anxiety, difficulty getting to sleep, awakening during the night, early morning awakening, backache, joint pain, forgetfulness, and difficulty concentrating (for hot flashes, P = 0.01; all others, P < 0.001). A final multivariate model included perceived health, stress, depressed mood, and difficulty concentrating. Interference with relationships was significantly associated with age and individual covariates such as perceived health, estrone, perceived stress, depressed mood, anxiety, sleep symptoms, backache, joint pain, forgetfulness, and difficulty concentrating (for estrone, P = 0.03; all others, P < 0.001). A final multivariate model included perceived health, stress, depressed mood, anxiety, difficulty concentrating, and awakening during the night.
CONCLUSIONS: Women's reports of how much the way they felt interfered with work and relationships were influenced by both their perceived health and stress levels. Interference was also influenced by depressed mood and difficulty concentrating, suggesting that these two symptoms may be most important to address, to enhance functioning during the MT and early PM.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21317821     DOI: 10.1097/gme.0b013e318205bd76

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  17 in total

1.  Symptom clusters during the late reproductive stage through the early postmenopause: observations from the Seattle Midlife Women's Health Study.

Authors:  Lori A Cray; Nancy Fugate Woods; Jerald R Herting; Ellen Sullivan Mitchell
Journal:  Menopause       Date:  2012-08       Impact factor: 2.953

2.  Effects of physical activity on vasomotor symptoms: examination using objective and subjective measures.

Authors:  Steriani Elavsky; Joaquin U Gonzales; David N Proctor; Nancy Williams; Victor W Henderson
Journal:  Menopause       Date:  2012-10       Impact factor: 2.953

3.  Characterization of neural estrogen signaling and neurotrophic changes in the accelerated ovarian failure mouse model of menopause.

Authors:  Tracey A Van Kempen; Jolanta Gorecka; Andreina D Gonzalez; Fumio Soeda; Teresa A Milner; Elizabeth M Waters
Journal:  Endocrinology       Date:  2014-06-13       Impact factor: 4.736

4.  Increased hot flash severity and related interference in perimenopausal human immunodeficiency virus-infected women.

Authors:  Sara E Looby; Jan Shifren; Inge Corless; Alison Rope; Maria C Pedersen; Hadine Joffe; Steven Grinspoon
Journal:  Menopause       Date:  2014-04       Impact factor: 2.953

5.  Pain Severity in Relation to the Final Menstrual Period in a Prospective Multiethnic Observational Cohort: Results From the Study of Women's Health Across the Nation.

Authors:  Yvonne C Lee; Arun S Karlamangla; Zhi Yu; Chih-Chin Liu; Joel S Finkelstein; Gail A Greendale; Siobán D Harlow; Daniel H Solomon
Journal:  J Pain       Date:  2016-11-09       Impact factor: 5.820

6.  Symptom Interference Severity and Health-Related Quality of Life in Pulmonary Arterial Hypertension.

Authors:  Lea Ann Matura; Annette McDonough; Diane L Carroll
Journal:  J Pain Symptom Manage       Date:  2015-08-20       Impact factor: 3.612

Review 7.  Diagnosis and Treatment of Anxiety in the Aging Woman.

Authors:  Andrew M Siegel; Sarah B Mathews
Journal:  Curr Psychiatry Rep       Date:  2015-12       Impact factor: 5.285

8.  Validity, cut-points, and minimally important differences for two hot flash-related daily interference scales.

Authors:  Janet S Carpenter; Giorgos Bakoyannis; Julie L Otte; Chen X Chen; Kevin L Rand; Nancy Woods; Katherine Newton; Hadine Joffe; JoAnn E Manson; Ellen W Freeman; Katherine A Guthrie
Journal:  Menopause       Date:  2017-08       Impact factor: 3.310

9.  Symptom clusters predict risk of metabolic-syndrome and diabetes in midlife: the Study of Women's Health Across the Nation.

Authors:  Alexis N Reeves; Michael R Elliott; Maria M Brooks; Carrie A Karvonen-Gutierrez; Irina Bondarenko; Michelle M Hood; Siobán D Harlow
Journal:  Ann Epidemiol       Date:  2021-02-22       Impact factor: 6.996

10.  Telephone-Based Cognitive Behavioral Therapy for Insomnia in Perimenopausal and Postmenopausal Women With Vasomotor Symptoms: A MsFLASH Randomized Clinical Trial.

Authors:  Susan M McCurry; Katherine A Guthrie; Charles M Morin; Nancy F Woods; Carol A Landis; Kristine E Ensrud; Joseph C Larson; Hadine Joffe; Lee S Cohen; Julie R Hunt; Katherine M Newton; Julie L Otte; Susan D Reed; Barbara Sternfeld; Lesley F Tinker; Andrea Z LaCroix
Journal:  JAMA Intern Med       Date:  2016-07-01       Impact factor: 44.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.